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A 92-year-old male with a history of right hemicolectomy for colonic adenocarcinoma two years 
prior presented with abdominal distension due to ascites. Computed tomography revealed a 
cystic mass in the region of the seminal vesicles (Figure 1A). 3000 ml of ascitic fluid was 
submitted for cytological analysis. Smears showed three-dimensional epithelial cell clusters 
with marked variation in nuclear size, pleomorphism, nuclear membrane irregularities and 
cytoplasmic vacuoles (Figure 1B-E). A papillary growth pattern could be appreciated both on 
smears and in the cell block. Immunocytochemical stainings performed on the cell block 
showed positivity for CK7, CA-125 and PAX8, while the tumor cells were negative for CDX2, 
GATA3, PSA, TTF1 and Calretinin. DNA mismatch repair enzymes MLH1, PMS2, MSH2 and 
MSH6 were intact. p53 showed a wildtype staining pattern with variably intense 
immunoreactivity in a minority of malignant cells (not shown). Molecular studies (Oncomine 
Comprehensive Panel v3 (DNA), Thermo Fisher Scientific) revealed an EGFR amplification 
(15 copies), which was accompanied by EGFR overexpression immunohistochemically. 
Furthermore, a SMARCB1 gene variant (c.1060_1061insG) was detected, which was 
bioinformatically predicted to be deleterious, but did not result in loss of expression as 
assessed by INI-1 immunohistochemistry (not shown). 
By comparison, the histological specimen of the colonic adenocarcinoma, available at our 
institute for re-evaluation, expressed CDX2, showed loss of expression of MLH1 and PMS2 
and was positive for V600E-mutant BRAF (not shown), indicating a sporadic microsatellite-
instable colon carcinoma.  
Given that secondary involvement of the seminal vesicles by other malignancies, especially by 
prostatic adenocarcinoma, is much more common than primary carcinoma, the bar for 
establishing the latter diagnosis is high. 
In the present case, immunostainings ruled out both recurrent colonic adenocarcinoma and 
prostatic adenocarcinoma. Expression of PAX8 – consistent with an origin from Müllerian 
epithelium1,2 – and CA-125 supported a diagnosis of primary adenocarcinoma of the seminal 
vesicles3, as did the imaging finding of a mass localized in the seminal vesicles.  
While the extent of nuclear pleomorphism and co-expression of CA-125 and PAX8 resembled 
features of high-grade serous carcinomas in females, p53 immunostaining showed a wildtype 
pattern. Furthermore, the distinct papillary architecture – which is considered an important 
diagnostic feature in histology – speaks against seminal vesicle adenocarcinoma representing 
a mere male counterpart of high-grade serous carcinoma. Further studies will be required to 
assess whether or not the EGFR amplification and the presumably pathogenic SMARCB1 
mutation found in the present case are characteristic of seminal vesicle adenocarcinoma in 
general.  
The seminal vesicles are notable for very low frequency of malignant transformation The 
largest published pathological series of carcinomas of the seminal vesicles comprises just four 
cases4. To our knowledge, this is the first documentation of both morphologic features of 
seminal vesicle carcinoma in cytology and underlying molecular alterations.  
Several factors were important to reach the diagnosis of a primary adenocarcinoma of the 
seminal vesicles in the present case: (1) the clinical context of a mass in the region of the 
seminal vesicles, (2) the exclusion of recurrent colonic adenocarcinoma by direct comparison 
of morphology and immunophenotype and (3) the characteristic co-expression of PAX8 and 
CA-125. We conclude from our findings, that the combination of marked nuclear pleomorphism 
and papillary growth pattern should raise the suspicion of seminal vesicle adenocarcinoma in 
ascites or possibly a fine needle aspiration specimen from a male patient. Once seminal vesicle 
adenocarcinoma has entered the differential diagnosis, PAX8 and CA-125 will be the most 
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Figure 1. Computed tomography showed a large cystic mass in the region of the seminal 
vesicles (A). Cytological smears of the ascites showed large, often papillary clusters of 
epithelial cells (B). There was marked variation in nuclear size, pleomorphism, nuclear 
membrane irregularities and cytoplasmic vacuoles (C-D). Papillae were also prominent in the 
cell block (E). Tumor cells were positive for PAX8 (F), CA-125 (G) and EGFR (H). B-C: 
Papanicolaou staining; D: Modified Romanowsky staining (Hemacolor®). E: Hematoxylin-
Eosin staining.  
 
